> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Cartiva Synthetic Cartilage Implant
- URL: https://www.fdaweb.com/panel-to-discuss-cartiva-synthetic-cartilage-implant/
- Published: 2016-03-07T12:00:00.000Z
- Updated: 2026-09-15T02:41:17.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134991

*Federal Register* Notice: FDA’s Orthopedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee will meet 4/20, from 8 a.m. to 6 p.m. at the Hilton Washington, DC/North, Salons A, B, C, and D, 620 Perry Pkwy., Gaithersburg, MD. The committee will discuss, make recommendations, and vote on a Cartiva Inc. PMA for the Cartiva Synthetic Cartilage Implant, an organic polymer-based biomaterial to mimic biologic cartilage, for treating degenerative and post-traumatic arthritis in the first metatarsophalangeal joint in the presence of good bone stock along with the following clinical conditions: hallux valgus or hallux limitus, hallux rigidus, and an unstable or painful metatarsophalangeal joint. Contact **S.J. Anderson**, email: Sara.Anderson@fda.hhs.gov, (301) 796-7047\. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-03-07/pdf/2016-04927.pdf?ref=fdaweb.com)